Suki, AI ambient scribe for healthcare, secures $90 million Series E from Healthier Capital, forecasts $60‑$80 million revenue.
agents healthcare
| Source: Techmeme | Original article
AI scribe startup Suki secured $90 million in Series E funding led by Healthier Capital and projects $60‑$80 million in revenue this year.
Suki, the AI‑driven ambient scribe that transcribes clinical encounters in real time, announced a $90 million Series E financing round led by Healthier Capital. The funding is earmarked for scaling the platform and expanding its suite of AI agents that assist healthcare providers with documentation and workflow automation. A source familiar with the company’s plans said Suki expects to generate between $60 million and $80 million in revenue this year.
The capital injection underscores growing investor confidence in AI tools that reduce administrative burdens in hospitals and clinics. By automating note‑taking, Suki aims to free clinicians to focus on patient care, a pressure point that has intensified as health systems grapple with staffing shortages and rising documentation requirements. The round also signals that venture capital is still flowing into niche AI applications despite broader market volatility.
Looking ahead, Suki’s next milestones will likely revolve around broader adoption across health systems and the rollout of new agent capabilities. Observers will watch for partnerships with electronic health‑record vendors, regulatory clearances that could affect deployment, and any indication of how the company plans to convert its projected revenue into sustainable profitability. The pace at which Suki can integrate its technology into existing clinical workflows will be a key barometer for the viability of ambient AI assistants in the broader healthcare ecosystem.
Sources
Back to AIPULSEN